beta-alanine has been researched along with Cardiac Failure in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the effects of dabigatran compared with warfarin in the subgroup of patients with previous symptomatic heart failure (HF) in the RE-LY trial." | 9.17 | Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial. ( Brueckmann, M; Connolly, SJ; Ezekowitz, MD; Ferreira, J; Fraessdorf, M; Reilly, PA; Wallentin, L; Yusuf, S, 2013) |
| "What is the central question of the study? Does β-alanine with l-histidine supplementation associated with endurance and strength training improve echocardiographic parameters, functional capacity, and maximum strength in rats with chronic heart failure? What is the main finding and its importance? β-Alanine with l-histidine supplementation associated with endurance and strength training increased functional capacity and maximum strength through increasing exercise capacity peripherally but did not affect echocardiographic parameters in rats with chronic heart failure." | 7.96 | β-Alanine and l-histidine supplementation associated with combined training increased functional capacity and maximum strength in heart failure rats. ( Capalonga, L; da Silva, LR; Dal Lago, P; Stefani, GP, 2020) |
| "It is a case report of bleeding when using dabigatran in patient with renal failure caused by the concurrent use of spironolactone and angiotensin-converting enzyme (ACE) inhibitors." | 7.79 | [Bleeding in the appointment of dabigatran in the patients with renal insufficiency caused by coadministration of spironolactone and ACE inhibitors]. ( Andreev, DA; Gappoeva, ZK; Giliarov, MIu; Sychev, DA, 2013) |
| "We evaluated the effects of dabigatran compared with warfarin in the subgroup of patients with previous symptomatic heart failure (HF) in the RE-LY trial." | 5.17 | Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial. ( Brueckmann, M; Connolly, SJ; Ezekowitz, MD; Ferreira, J; Fraessdorf, M; Reilly, PA; Wallentin, L; Yusuf, S, 2013) |
| "What is the central question of the study? Does β-alanine with l-histidine supplementation associated with endurance and strength training improve echocardiographic parameters, functional capacity, and maximum strength in rats with chronic heart failure? What is the main finding and its importance? β-Alanine with l-histidine supplementation associated with endurance and strength training increased functional capacity and maximum strength through increasing exercise capacity peripherally but did not affect echocardiographic parameters in rats with chronic heart failure." | 3.96 | β-Alanine and l-histidine supplementation associated with combined training increased functional capacity and maximum strength in heart failure rats. ( Capalonga, L; da Silva, LR; Dal Lago, P; Stefani, GP, 2020) |
| "It is a case report of bleeding when using dabigatran in patient with renal failure caused by the concurrent use of spironolactone and angiotensin-converting enzyme (ACE) inhibitors." | 3.79 | [Bleeding in the appointment of dabigatran in the patients with renal insufficiency caused by coadministration of spironolactone and ACE inhibitors]. ( Andreev, DA; Gappoeva, ZK; Giliarov, MIu; Sychev, DA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, T | 1 |
| Wang, R | 1 |
| Zhang, H | 1 |
| Zhao, F | 1 |
| Stefani, GP | 2 |
| Capalonga, L | 2 |
| da Silva, LR | 2 |
| Dal Lago, P | 2 |
| Heck, TG | 1 |
| Frizzo, MN | 1 |
| Sulzbacher, LM | 1 |
| Sulzbacher, MM | 1 |
| de Batista, D | 1 |
| Vedovatto, S | 1 |
| Bertoni, APS | 1 |
| Wink, MR | 1 |
| Andreev, DA | 1 |
| Gappoeva, ZK | 1 |
| Sychev, DA | 1 |
| Giliarov, MIu | 1 |
| Heidenreich, PA | 1 |
| Boos, CJ | 1 |
| Nam, M | 1 |
| Camm, AJ | 1 |
| Ferreira, J | 1 |
| Ezekowitz, MD | 1 |
| Connolly, SJ | 1 |
| Brueckmann, M | 1 |
| Fraessdorf, M | 1 |
| Reilly, PA | 1 |
| Yusuf, S | 1 |
| Wallentin, L | 1 |
| Müller, P | 1 |
| Topakian, R | 1 |
| Sonnberger, M | 1 |
| Nußbaumer, K | 1 |
| Windpessl, M | 1 |
| Eder, V | 1 |
| Nesser, HJ | 1 |
| Trenkler, J | 1 |
| Haring, HP | 1 |
| Van Gelder, IC | 1 |
| Van Veldhuisen, DJ | 1 |
| Lip, GY | 1 |
| Olesen, JB | 1 |
| Sørensen, R | 1 |
| Hansen, ML | 1 |
| Lamberts, M | 1 |
| Weeke, P | 1 |
| Mikkelsen, AP | 1 |
| Køber, L | 1 |
| Gislason, GH | 1 |
| Torp-Pedersen, C | 1 |
| Fosbøl, EL | 1 |
| Gastineau, DA | 1 |
| Gertz, MA | 1 |
| Daniels, TM | 1 |
| Kyle, RA | 1 |
| Bowie, EJ | 1 |
1 review available for beta-alanine and Cardiac Failure
| Article | Year |
|---|---|
Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Chronic Disease; Dabigatran; Drug | 2014 |
1 trial available for beta-alanine and Cardiac Failure
| Article | Year |
|---|---|
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response R | 2013 |
9 other studies available for beta-alanine and Cardiac Failure
| Article | Year |
|---|---|
Network pharmacology combined with metabolomics reveals the mechanism of Fuzi decoction against chronic heart failure in rats.
Topics: Animals; beta-Alanine; Chronic Disease; Coenzyme A; Diterpenes; Drugs, Chinese Herbal; Glycine; Glyo | 2022 |
β-Alanine and l-histidine supplementation associated with combined training increased functional capacity and maximum strength in heart failure rats.
Topics: Animals; beta-Alanine; Carnosine; Dietary Supplements; Echocardiography; Heart Failure; Histidine; M | 2020 |
Effects of aerobic and resistance exercise training associated with carnosine precursor supplementation on maximal strength and V̇O
Topics: Animals; beta-Alanine; Carnosine; Disease Models, Animal; Heart Failure; Histidine; Male; Oxygen; Ph | 2021 |
[Bleeding in the appointment of dabigatran in the patients with renal insufficiency caused by coadministration of spironolactone and ACE inhibitors].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Benzimidazoles; beta-Alanine; C | 2013 |
Placing a value on new technologies.
Topics: Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coronary Occlusion; Dabigatran; | 2013 |
Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran.
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia | 2013 |
New oral anticoagulants in heart failure.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Failure | 2013 |
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; be | 2015 |
Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality.
Topics: Amyloidosis; beta-Alanine; Blood Coagulation Disorders; Fibrinogen; Heart Failure; Humans; Nephrotic | 1991 |